The effect of alpha2 adrenergic agonist drugs and their antagonists on respiratory blood gases in conscious sheepNo abstract is available for this article.doi:10.1111/j.1467-2995.1986.tb00329.xA.E. WatermanA. NolanA. LivingstonJohn Wiley & Sons, Ltd....
Effective treatments of pain and/or inflammation are provided. Through the administration of an effective amount of at least one alpha adrenergic agonist at or near a target site, o
SKF 38393, a selective Dl agonist, and dopamine in the presence of sulpiride both excite the neurons. These results provide data that the dopamine inhibitory response on Lymnaea growth-hormone-producing cells is of the D2 type, while the excitation which can be revealed when the inhibition is...
2 In isolated tissues the blockade by labetal... RT Brittain,GP Levy - 《Br J Clin Pharmacol》 被引量: 275发表: 1976年 A comparison of the beta-adrenoceptor agonist potency of labetalol with those of sympathomimetic drugs, and the role of alpha-receptors in pharmacological ... 1 The ...
Release of different α-granule components may be differentially regulated depending on the agonist used. View chapterExplore book Platelet Secretion Robert Flaumenhaft, in Platelets (Third Edition), 2013 1 α-Granules in Inflammation Accumulating evidence demonstrates that platelets contribute to the ...
Appetite Regulation: ALPHA-MSH is also involved in the regulation of appetite. It acts on the hypothalamus to suppress appetite and promote satiety. This mechanism of action makes it a potential target for the development of anti-obesity drugs. Storage ...
The present disclosure relates to pharmaceutical compositions comprising a therapeutically effective amount of a selective alpha-adrenergic receptor agonist or an anticholinergic ag
Tukey's post hoc analysis revealed that intra-NAc terazosin attenuated the locomotor activating effects of both drugs (Figures 2a and b). By contrast, there was only a main effect of treatment in the VTA for cocaine (F(1, 19) ¼ 30.4, po0.0001) and morphine (F(1, 23) ¼ 31.28,...
(3–36). Similar results were obtained when PYY was combined with VES in either breastcancer cells[11]or with RRR-α-tocopheryl succinate and the Y4agonistBA-129 inprostate cancercell growth studies[26]. At present, there have been no studies performed using the combined treatment of Vitamin...
An agonist of group II metabotropic glutamate receptors, (2S,2'R,3'R)-2-(2',3'-Dicarboxycyclopropyl)glycine (DCG-IV), which selectively suppresses the MF input, was applied at the end of each experiment. DCG-IV was less effective in mutant mice (92.8 ± 1.0% block in wild-type ...